AtriCure, Inc.

AtriCure, Inc. is a medical device manufacturer specializing in surgical solutions for atrial fibrillation (Afib) management and post-operative pain management. The company's primary product portfolio centers on left atrial appendage (LAA) exclusion and surgical ablation devices. The AtriClip device family represents the company's flagship offering, with over 750,000 procedures performed worldwide and 672,000 devices sold globally. AtriClip variants include AtriClip FLEX-Mini, AtriClip Mini, and EnCompass, designed to support diverse surgical approaches from minimally invasive procedures to complex anatomies. The BoxX surgical ablation system enables comprehensive Afib treatment during cardiac procedures such as coronary artery bypass grafting (CABG). AtriCure also offers Hybrid AF Therapy, combining percutaneous and surgical approaches for long-standing persistent Afib patients. Additionally, the company manufactures cryoICE and cryoXT technologies for cryo nerve block procedures, providing non-opioid post-amputation pain management solutions. Clinical evidence supporting the product portfolio includes over 100 published studies demonstrating 100% LAA closure rates with zero leaks and zero serious adverse events at 30 days. The company serves cardiac surgeons, electrophysiologists, and general cardiologists across hospital and surgical center settings globally. Products are designed for use in operating rooms and cardiac catheterization laboratories.